History 1 페이지

About IMMUSE Therapeutics

History

History of IMMUSE Therapeutics

  • 2024
    • Selected as Korea Drug Development Fund's(IMT-105)
  • 2023
    • Selected as a Military Service Exception Designated Company
    • Nomination of JLABS(@Shanghai) residency
    • Establishing US corporation(IMMUSE Pharmaceuticals, Inc.)
  • 2022
    • Pre-A Funding
    • Establishing R&D Center
    • Relocation of HQ (Seoul, Korea)
    • Certification of Venture Enterprise
  • 2021
    • Angel Funding
    • Foundation (IMMUSE Therapeutics, Inc.)
go top